Literature DB >> 24771043

Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.

Cao Chen1, Yan Lv, Bao-Yun Zhang, Jin Zhang, Qi Shi, Jing Wang, Chan Tian, Chen Gao, Kang Xiao, Ke Ren, Wei Zhou, Xiao-Ping Dong.   

Abstract

It has been described that A disintegrin and metalloproteinase (ADAM10) may involve in the physiopathology of prion diseases, but the direct molecular basis still remains unsolved. In this study, we confirmed that ADAM10 was able to cleave recombinant human prion protein in vitro. Using immunoprecipitation tests (IP) and immunofluorescent assays (IFA), reliable molecular interaction between the native cellular form of PrP (PrP(C)) and ADAM10 was observed not only in various cultured neuronal cell lines but also in brain homogenates of healthy hamsters and mice. Only mature ADAM10 (after removal of its prodomain) molecules showed the binding activity with the native PrP(C). Remarkably more prion protein (PrP)-ADAM10 complexes were detected in the membrane fraction of cultured cells. In the scrapie-infected SMB cell model, the endogenous ADAM10 levels, especially the mature ADAM10, were significantly decreased in the fraction of cell membrane. IP and IFA tests of prion-infected SMB-S15 cells confirmed no detectable PrP-ADAM10 complex in the cellular lysates and PrP-ADAM10 co-localization on the cell surface. Furthermore, we demonstrated that the levels of ADAM10 in the brain homogenates of scrapie agent 263K-infected hamsters and agent ME7-infected mice were also almost diminished at the terminal stage, showing time-dependent decreases during the incubation period. Our data here provide the solid molecular basis for the endoproteolysis of ADAM10 on PrP molecules and interaction between ADAM10 and PrP(C). Obvious loss of ADAM10 during prion infection in vitro and in vivo highlights that ADAM10 may play essential pathophysiological roles in prion replication and accumulation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771043     DOI: 10.1007/s12035-014-8708-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

Review 1.  ADAM proteins in the brain.

Authors:  Ulrike Novak
Journal:  J Clin Neurosci       Date:  2004-04       Impact factor: 1.961

Review 2.  Shedding light on ADAM metalloproteinases.

Authors:  Ari-Pekka J Huovila; Anthony J Turner; Markku Pelto-Huikko; Iivari Kärkkäinen; Rebekka M Ortiz
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

3.  Molecular interaction between prion protein and GFAP both in native and recombinant forms in vitro.

Authors:  Chen-Fang Dong; Xiao-Fan Wang; Xin Wang; Song Shi; Gui-Rong Wang; Bing Shan; Run An; Xiao-Li Li; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2007-12-18       Impact factor: 3.402

4.  Characterization of the prion protein 3F4 epitope and its use as a molecular tag.

Authors:  Christoffer Lund; Christel Moraeus Olsen; Heidi Tveit; Michael A Tranulis
Journal:  J Neurosci Methods       Date:  2007-06-13       Impact factor: 2.390

Review 5.  The ADAMs: signalling scissors in the tumour microenvironment.

Authors:  Gillian Murphy
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

6.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

7.  Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.

Authors:  Moustapha Alfa Cissé; Céline Gandreuil; Jean-François Hernandez; Jean Martinez; Frédéric Checler; Bruno Vincent
Journal:  Biochem Biophys Res Commun       Date:  2006-06-21       Impact factor: 3.575

8.  Multiplication of the scrapie agent.

Authors:  D A Haig; M C Clarke
Journal:  Nature       Date:  1971-11-12       Impact factor: 49.962

9.  The N-terminal cleavage of cellular prion protein in the human brain.

Authors:  Isabelle Laffont-Proust; Baptiste A Faucheux; Raymonde Hässig; Véronique Sazdovitch; Stéphanie Simon; Jacques Grassi; Jean-Jacques Hauw; Kenneth L Moya; Stéphane Haïk
Journal:  FEBS Lett       Date:  2005-10-19       Impact factor: 4.124

10.  Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.

Authors:  Jian-Ming Chen; Chen Gao; Qi Shi; Bing Shan; Yan-Jun Lei; Chen-Fang Dong; Run An; Gui-Rong Wang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Arch Virol       Date:  2008-04-11       Impact factor: 2.574

View more
  4 in total

1.  Decrease of RyR2 in the prion infected cell line and in the brains of the scrapie infected mice models and the patients of human prion diseases.

Authors:  Qi Shi; Jian-Le Li; Yue Ma; Li-Ping Gao; Kang Xiao; Jing Wang; Wei Zhou; Cao Chen; Yan-Jun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2018-06-07       Impact factor: 3.931

2.  Alternative complement pathway is activated in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Chao Hu; Xiao-Feng Xu; Ren-Qing Zhang; Kang Xiao; Yue Ma; Li-Ping Gao; Jian-Le Li; Qiang Shi; Jing Wang; Qi Shi; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2019-11-12       Impact factor: 3.402

3.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

4.  Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Authors:  Chao Hu; Cao Chen; Ying Xia; Jia Chen; Wei Yang; Lin Wang; Dong-Dong Chen; Yue-Zhang Wu; Qin Fan; Xiao-Xi Jia; Kang Xiao; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Front Cell Dev Biol       Date:  2022-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.